tiprankstipranks
Holding CNCR?
Track your performance easily

CNCR Price & Analysis

CNCR ETF Chart & Stats

Day’s Range― - ―
52-Week Range$9.22 - $17.96
Previous Close$15.04
VolumeN/A
Average Volume (3M)9.44K
AUM13.56M
NAV15.02
Expense Ratio0.79%
Holdings Count77
Beta1.16
Inception DateOct 13, 2015
Dividend YieldN/A
Shares Outstanding1,250,000
Standard Deviation0.09
10 Day Avg. Volume12,698
30 Day Avg. Volume9,436
Alpha-0.01

Loncar Cancer Immunotherapy ETF (CNCR) Fund Flow Chart

Loncar Cancer Immunotherapy ETF (CNCR) 1 year Net Flows: $1M

CNCR ETF FAQ

What was CNCR’s price range in the past 12 months?
CNCR lowest ETF price was $9.22 and its highest was $17.96 in the past 12 months.
    What is the AUM of CNCR?
    As of Jul 22, 2024 The AUM of CNCR is 13.56M.
      Is CNCR overvalued?
      According to Wall Street analysts CNCR’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does CNCR pay dividends?
        CNCR pays a Annually dividend of $1.85 which represents an annual dividend yield of N/A. See more information on CNCR dividends here
          How many shares outstanding does CNCR have?
          CNCR has 1,250,000 shares outstanding.
            Which hedge fund is a major shareholder of CNCR?
            Currently, no hedge funds are holding shares in CNCR

            CNCR ETF Smart Score

            For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

            Top 10 Holdings

            Name
            Weight %
            Geron Corporation
            3.80%
            Enliven Therapeutics, Inc.
            2.76%
            Summit Therapeutics PLC
            2.68%
            Nurix Therapeutics, Inc.
            2.14%
            Iteos Therapeutics, Inc.
            2.12%
            Acrivon Therapeutics, Inc.
            2.09%
            Revolution Medicines, Inc.
            2.09%
            Erasca, Inc.
            2.05%
            Nuvation Bio Inc
            1.98%
            Blueprint Medicines Corp.
            1.90%
            Total23.61%

            ETF Description

            Loncar Cancer Immunotherapy ETF

            CNCR tracks an equal-weighted index of companies currently developing oncology drugs or selling cancer therapeutic products.
            Sector
            Sector
            Asset Class
            Equity
            Region
            Global
            Issuer
            Range
            Index Tracked
            Range Oncology Therapeutics Index
            Ticker Symbol
            CNCR
            Popular ETFs
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis